Wakix

Approved Uses

Wakix is used to manage symptoms associated with narcolepsy, a chronic neurological disorder that affects the brain's ability to control sleep-wake cycles. It is specifically indicated for the treatment of:

• Excessive Daytime Sleepiness (EDS): This is a condition where a person experiences an overwhelming urge to sleep during the day, regardless of how much sleep they get at night.
• Cataplexy: This involves sudden, temporary muscle weakness or a loss of muscle control, typically triggered by strong emotions such as laughter, surprise, or anger.

Target Population

This medication is approved for use in adults. It is intended to help patients maintain alertness and reduce the frequency of muscle weakness episodes during waking hours. Unlike many other medications used for narcolepsy, it is not classified as a controlled substance.

Mechanism of Action

The exact way Wakix works to improve wakefulness is not fully understood. However, it is believed to work by targeting histamine 3 (H3) receptors in the brain. Unlike many other medications used for narcolepsy, Wakix is not a traditional stimulant.

Increasing Histamine Levels

Histamine is a neurotransmitter that plays a vital role in keeping the brain awake and alert. Wakix acts as an H3 receptor antagonist and inverse agonist. This process involves:

• Blocking H3 receptors: These receptors normally act as a control mechanism to limit the release of histamine. By blocking them, the medication prevents the brain from shutting down histamine production.
• Promoting wakefulness: By allowing more histamine to be released, the medication helps the brain stay in a wakeful state, which reduces excessive daytime sleepiness.
• Reducing cataplexy: By modulating these chemical signals, the medication also helps control cataplexy, which is the sudden loss of muscle tone often triggered by strong emotions.

By increasing the activity of histamine-producing neurons, Wakix helps stabilize the sleep-wake cycle for adults living with narcolepsy.

Common Side Effects

Many people using Wakix experience mild side effects. These may include:

• Insomnia or difficulty sleeping
• Nausea
• Headache
• Upper respiratory tract infections
• Musculoskeletal pain
• Anxiety
• Increased heart rate
• Hallucinations or irritability
• Abdominal pain
• Decreased appetite
• Dry mouth
• Rash

Serious Side Effects

Some side effects require immediate medical attention. Contact a healthcare provider right away if you notice:

• Heart Rhythm Changes: Wakix can cause QT prolongation, which is a change in the electrical activity of the heart.
• Severe Allergic Reactions: Signs include hives, swelling of the face or throat, and difficulty breathing.
• Mental Health Changes: New or worsening depression, anxiety, or suicidal thoughts and behaviors.

Heart Rhythm Changes

Wakix can cause a condition known as QT prolongation, which is a change in the electrical activity of the heart. This change can increase the risk of serious heart rhythm disturbances. Healthcare providers typically avoid prescribing this medication to individuals with a history of certain heart conditions or those taking other drugs that also affect heart rhythm. Risk factors may include:

• A history of cardiac arrhythmias or other heart diseases.
• Low levels of potassium or magnesium in the blood.
• Concurrent use of other medications known to prolong the QT interval.

Liver and Kidney Function

The body relies on the liver and kidneys to process and eliminate pitolisant. Specific precautions include:

• Liver Disease: This medication is contraindicated in individuals with severe liver impairment. Those with moderate liver impairment may require a dosage adjustment.
• Kidney Disease: Individuals with moderate to severe kidney disease may require a lower dose. Use is generally not recommended for those with end-stage renal disease.

Medication Interactions

Wakix may interact with other drugs, which can change how the medication works or increase the risk of side effects. For example, certain medications used to treat depression or infections may increase the levels of Wakix in the blood. Conversely, some medications used for seizures or other conditions may decrease its effectiveness. It is important for healthcare providers to review all current medications, including over-the-counter products and supplements.

Pregnancy and Breastfeeding

The safety of Wakix during pregnancy or while breastfeeding has not been fully established. There is limited data on whether the drug passes into human breast milk or its effects on a developing fetus. Healthcare providers typically evaluate the potential benefits and risks before recommending use in these situations.

Pregnancy

The safety of Wakix during human pregnancy has not been established due to a lack of clinical data. In animal studies, high doses of the medication were associated with reduced fetal weight and delayed physical development. Because the risks to a developing fetus are not fully understood, healthcare providers typically only prescribe this medication during pregnancy if the potential benefits outweigh the potential risks.

A pregnancy registry is available to monitor the health of individuals who take Wakix while pregnant. This registry helps researchers collect data to better understand the drug's impact on pregnancy outcomes.

Birth Control

Wakix can interfere with the way the body processes hormonal contraceptives, potentially making them less effective. This includes birth control pills, patches, vaginal rings, and certain implants. Individuals using hormonal contraception are advised to use an alternative, non-hormonal method (such as condoms or a copper IUD) during treatment and for at least 21 days after their last dose of Wakix.

Breastfeeding

It is not known whether Wakix passes into human breast milk. Animal studies have shown that the drug is present in the milk of lactating rats. Because the potential effects on a nursing infant are unknown, it is important to discuss the risks and benefits of breastfeeding with a healthcare provider before using this medication.

Dosage Forms

Wakix is available in the following form:

• Oral Tablet: This medication is a film-coated tablet intended for oral administration.

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Wakix in 2019 for the treatment of excessive daytime sleepiness in adults with narcolepsy. Its approved uses were later expanded to include the treatment of cataplexy (sudden muscle weakness) in adults and excessive daytime sleepiness in pediatric patients aged 6 years and older.

Regulatory Classification

Unlike many other medications used to treat narcolepsy symptoms, Wakix is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA). Clinical studies indicated that the medication does not have a significant potential for abuse or physical dependence.

Safety Warnings and Monitoring

While Wakix does not carry a boxed warning, the FDA-approved labeling includes several important safety considerations and contraindications:

• Liver Impairment: Wakix is contraindicated in patients with severe hepatic (liver) impairment, as the body may not be able to process the medication safely.
• Heart Rhythm: The medication is associated with a warning for QT prolongation, which is a change in the heart's electrical activity. It should be avoided in patients with known heart rhythm conditions or those taking other medications that also prolong the QT interval.
• Kidney Function: Dosage adjustments are required for patients with moderate to severe renal (kidney) impairment.

There is currently no Risk Evaluation and Mitigation Strategy (REMS) program required for the prescription or distribution of this medication.

Insurance and Pharmacy Factors

The amount you pay for Wakix is largely determined by your health insurance coverage. Most insurance plans require a prior authorization before they will cover the medication. Because Wakix is a specialty drug, it is usually dispensed through a specialty pharmacy rather than a local retail pharmacy. These pharmacies coordinate with your insurance provider to determine your out-of-pocket costs.

Brand-Name Status

Wakix is currently only available as a brand-name medication. There is no generic version of pitolisant available at this time. Generic drugs typically cost significantly less than brand-name versions.

Financial Assistance

The manufacturer provides a support program known as Wakix for You. This program is designed to help patients access the medication through various means:

• Copay Assistance: Eligible patients with commercial insurance may qualify for a copay card to reduce out-of-pocket expenses.
• Patient Assistance Program: Patients who are uninsured or meet certain financial criteria may be eligible to receive the medication at no cost.
• Coverage Support: The program can help navigate the insurance approval process and identify potential ways to lower costs.